Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
OMNI
company
About
OMNI is a pharmaceutical company that focuses on drug delivery technologies.
- 251 - 500
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥20M
- Industries
- Biotechnology,Health Care,Medical Device,Pharmaceutical
- Founded date
- Jan 1, 2011
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
¥33M
OMNI has raised a total of
¥33M
in funding over 2 rounds. Their latest funding was raised on
Dec 27, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 27, 2021 | Series D | — | 1 | — | — | Detail |
| Sep 29, 2017 | Series B | ¥20M | 2 | — | — | Detail |
| Sep 22, 2015 | Series A | ¥10M | 2 | — | — | Detail |
| Feb 19, 2013 | Angel | ¥3M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
6
OMNI is funded by 6 investors.
Haimen Pushi Yiyao
and Zhangkelingyi
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Angel |
|
|
— | Series D |
|
|
— | Series B |
|
|
— | Series B |
|
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
